Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.

Nuclear medicine communications - 1 Oct 2020

Singh Deepa, Shukla Jaya, Walia Rama, Vatsa Rakhee, Paul Nandini, Chhabra Anupriya, Nahar Uma, Singh Harmandeep, Kumar Rajender, Bhansali Anil, Rai Mittal Bhagwant

Abstract excerpt

PURPOSE: The primary aim of study was to compare role of iodine-131 (I-131)-labeled metaiodobenzylguanidine ([I]MIBG) and gallium-68 (Ga-68)-labeled DOTA-l-Nal3-octreotide ([Ga]DOTANOC) PET/computed tomography (CT) in patients with pheochromocytoma (PCC) and paraganglioma (PGL), subsequent follow-up to see management. The secondary aim was to see association of germline mutation in histopathologically proven...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Organometallic Compounds

Share to Paraganglioma

Share to Pheochromocytoma

Share to Positron Emission Tomography Computed Tomography

Share to Young Adult

Source

Identifiers

PMID: 32732602
DOI: 10.1097/MNM.0000000000001251

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.PMID 32732602Read ↗

Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.Semantic proximity Read ↗

Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroupsSemantic proximity Read ↗

HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshopSemantic proximity Read ↗

Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma.Semantic proximity Read ↗

Imaging of Pheochromocytoma and ParagangliomaSemantic proximity Read ↗

Comparison of 131I-MIBG, 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT scans in a patient with extra adrenal paraganglioma associated with SDH-B gene mutation.Semantic proximity Read ↗

Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic optionsSemantic proximity Read ↗

PET detectives: Molecular imaging for phaeochromocytomas and paragangliomas in the genomics eraSemantic proximity Read ↗

Metastatic pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment.Semantic proximity Read ↗

Genetic and clinical investigation of pheochromocytoma: a 22-year experience, from Freiburg, Germany to international effort.Semantic proximity Read ↗

Recent Advances in Genetics, Diagnosis, Localization, and Treatment of PheochromocytomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.